Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Chronic Lymphocytic Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.

Share this video  

ERIC 2024 | Exploring the role of non-coding RNAs in CLL biology

Marek Mráz • 27 Sep 2024
ERIC 2024
Chronic Lymphocytic Leukemia Leukemia

Marek Mráz, PhD, Central European Institute of Technology, Brno, Czech Republic, discusses the significance of long non-coding RNAs in relation to chronic lymphocytic leukemia (CLL) and points out the need for more research on their roles in immunity and the biology of CLL cells. This interview took place at the 2024 European Research Initiative on CLL (ERIC) Meeting in Barcelona, Spain.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Marek Mráz

Non-genetic adaptation to BTK inhibitors in CLL 3:23
Non-genetic adaptation to BTK inhibitors in CLL
Marek Mráz • 7 Dec 2024
Engineering stromal cells to express T-cell factors to induce CLL cell proliferation 1:15
Engineering stromal cells to express T-cell factors to induce CLL cell proliferation
Marek Mráz • 27 Sep 2024
Transcription factor FoxO1 mediates cell survival during BCR inhibitor therapy in CLL 2:01
Transcription factor FoxO1 mediates cell survival during BCR inhibitor therapy in CLL
Marek Mráz • 7 Oct 2023
CLL resistance mechanisms in the era of novel agents 1:01
CLL resistance mechanisms in the era of novel agents
Marek Mráz • 7 Oct 2023

Related Videos

The value and mission of the International Workshop on Acute Leukemias 14:36
The value and mission of the International Workshop on Acute Leukemias
Charles Craddock et al. • 21 Oct 2025
One big question with Koichi Takahashi: what AML advance could transform frontline care in 3 years? 1:30
One big question with Koichi Takahashi: what AML advance could transform frontline care in 3 years?
Koichi Takahashi • 26 Sep 2025
One big question with Naval Daver: what AML advance could transform frontline care in three years? 1:05
One big question with Naval Daver: what AML advance could transform frontline care in three years?
Naval Daver • 26 Sep 2025
One big question with Charles Craddock: what AML advance could transform frontline care in 3 years? 3:13
One big question with Charles Craddock: what AML advance could transform frontline care in 3 years?
Charles Craddock • 26 Sep 2025
The content of VJHemOnc is intended for healthcare professionals